High‐throughput proteomic analysis of chronic inflammatory skin diseases: Psoriasis and atopic dermatitis
Experimental Dermatology · 2024
DOI: 10.1111/exd.15079 ↗Kurz gefasst
Fachartikel in der Zeitschrift Experimental Dermatology, 2024. Verfasst von Tanel Traks und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology and Venereology, Institute of Clinical Medicine, University of Tartu, Tartu, Estonia. Hauptthemen laut MEDLINE: Dermatitis, Atopic, Psoriasis, Proteomics, Cell Adhesion Molecules. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Eesti Teadusagentuur.
Abstract (Originalsprache)
Common characteristics in the pathogenesis of psoriasis (PS) and atopic dermatitis (AD) have been presumed, but only a few studies have clearly supported this. The current aim was to find possible similarities and differences in protein expression patterns between these two major chronic inflammatory skin diseases. High‐throughput tandem mass spectrometry proteomic analysis was performed using full thickness skin samples from adult PS patients, AD patients and healthy subjects. We detected a combined total of 3045 proteins in the three study groups. According to principal component analysis, there was significant overlap between the proteomic profiles of PS and AD, and both clearly differed from that of healthy skin. The following validation of selected proteins with western blot analysis showed similar tendencies in expression levels and produced statistically significant results. The expression of periostin (POSTN) was consistently high in AD and very low or undetectable in PS (5% FDR corrected p < 0.001), suggesting POSTN as a potential biomarker to distinguish these diseases. Immunohistochemistry further confirmed higher POSTN expression in AD compared to PS skin. Overall, our findings support the concept that these two chronic skin diseases might share considerably more common mechanisms in pathogenesis than has been suspected thus far.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Dermatology and Venereology, Institute of Clinical Medicine, University of Tartu, Tartu, Estonia.
- Clinical Research Centre, Tartu University Hospital, University of Tartu, Tartu, Estonia.
- Department of Physiology, Institute of Biomedicine and Translational Medicine, University of Tartu, Tartu, Estonia.
- Estonian Genome Centre, Institute of Genomics, University of Tartu, Tartu, Estonia.
- Institute of Physics, University of Tartu, Tartu, Estonia.
- Dermatology Clinic, Tartu University Hospital, Tartu, Estonia.
ORCID-Profile: Tanel Traks
Förderung
- Eesti Teadusagentuur
Zitieren
APA
Traks, T., Reemann, P., Eskla, K. L., Ottas, A., Jagomäe, T., Liira, R., Ilves, L., Jaks, V., Raam, L., Abram, K., & Kingo, K. (2024). High‐throughput proteomic analysis of chronic inflammatory skin diseases: Psoriasis and atopic dermatitis. Experimental Dermatology. https://doi.org/10.1111/exd.15079
Vancouver
Traks T, Reemann P, Eskla KL, Ottas A, Jagomäe T, Liira R, et al. High‐throughput proteomic analysis of chronic inflammatory skin diseases: Psoriasis and atopic dermatitis. Experimental Dermatology. 2024. doi:10.1111/exd.15079
BibTeX
@article{Traks2024,
author = {Traks, Tanel and Reemann, Paula and Eskla, Kattri-Liis and Ottas, Aigar and Jagomäe, Toomas and Liira, Rasmus and Ilves, Liis and Jaks, Viljar and Raam, Liisi and Abram, Kristi and Kingo, Külli},
title = {High‐throughput proteomic analysis of chronic inflammatory skin diseases: Psoriasis and atopic dermatitis},
journal = {Experimental Dermatology},
year = {2024},
doi = {10.1111/exd.15079}
}
EUVIMED